A Carnegie Mellon Researcher Raises $35 Million For Clinical Intelligence

Forbes
Read full story
Carnegie Mellon spinout Xlue secured $35 million in funding from Conviction, Sarah Guo's venture capital firm, to develop AI tools for identifying patients at high risk of cancer.


More in Healthcare